Bioxytran, Inc.

BIXT ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2019

Total Assets: $219.6K

Liabilities Breakdown FY2019

Total Liabilities: $1.0M